Lauren C. Friedlander, MD

Expertise in: 
Breast Cancer
Board Certifications: 
Diagnostic Radiology
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Breast Cancer, Breast Ultrasound, Breast MRI, Breast Biopsy, Breast Biopsies, Diagnostic Radiology, Breast Imaging

Academic Appointments

  • Assistant Professor of Clinical Radiology

Dr. Lauren Friedlander is an Assistant Professor of Radiology for Columbia University Medical Center at New York Presbyterian Hospital and for New York-Presbyterian/Lawrence Hospital. She is board certified in Diagnostic Radiology and has subspecialty training in Breast Imaging, having completed a Breast and Body Imaging fellowship at Memorial Sloan Kettering Cancer Center. She completed diagnostic radiology residency training at the Hospital of the University of Pennsylvania after graduating from Harvard Medical School. She is experienced in all aspects of breast imaging, including mammography, tomosynthesis, breast ultrasound, breast MRI, and breast biopsies. She is a member of the Radiological Society of North America, the American Roentgen Ray Society, the American College of Radiology, the Society of Breast Imaging, the New York Breast Imaging Society, and the New York Roentgen Society.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Lawrence Hospital

Gender

  • Female

Insurance Accepted

For billing questions, please call (866) 815-6994.

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

TRICARE

  • TRICARE

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Harvard Medical School
  • Internship: Mount Sinai Medical Center
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Memorial Sloan-Kettering Cancer Center

Board Certifications

  • Diagnostic Radiology

Research

Selected Publications

Peer-reviewed Articles

  • Ha R, Chow D, Mango V, Friedlander L, Wynn R. Bridging the racial gap. National trend in African-American women breast cancer research productivity from 1992 to 2012. Breast J. 2015; 21 (4):442-4.
  • Friedlander LC, Gavenonis S, Roth S. Results of MRI screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011; 261 (2):421-7.
  • Canter LM, Howell E, Torigian D. Chest radiographic and computed tomographic findings of the temporary total artificial heart (TAH-t). J Thorac Imaging. 2008; 23(4):269-271.
  • Ostfeld RS, Roy P, Haumaier W, Canter L, Keesing F, Rowton ED. Sand fly (Lutzomyia vexator) (Diptera: Psychodidae) populations in upstate New York: abundance, microhabitat, and phenology. J Med Entomol. 2004 Jul;41(4):774-8.

Review Articles

  • Canter LM. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc. 2005 May/June.

Abstracts and Presentations

  • Ha R, Mango V, Friedlander L, Alkhalili R, Desperito E, WynnR. Are technical recall rates a reliable quality metric for mammographic positioning? Presented electronically at the 115th Annual Meeting of the ARRS, April 2015, Toronto.
  • Ha R, Jin B, Mango V, Friedlander L, Alkhalili R, Desperito E, Wynn R. Are patients with high breast MRI background parenchymal enhancement at greater risk for breast cancer molecular subtype (HER2+ and Basal) with poor prognosis? Presented electronically at the 115th Annual Meeting of the ARRS, April 2015, Toronto.
  • Ha R, Jin B, Mango V, Friedlander L, Alkhalili R, Desperito E, Wynn R. Are patients with high breast MRI background parenchymal enhancement at greater risk for more proliferative (high Ki-67 index) breast cancers? Presented electronically at the 115th Annual Meeting of the ARRS, April 2015, Toronto.
  • Kwak E, Mango V, Patel S, Friedlander L, Wynn R, Ha R. Personalized pre-operative breast MRI: Selecting patients based on breast cancer prognostic factors. Presented orally at the Society of Breast Imaging/American College of Radiology Breast Imaging Symposium April 2015, Orlando.
  • Mema E, Kwak E, Mango V, Friedlander L, Desperito E, Alkhalili R, Wynn R, Ha R. Are patients with high breast MRI background parenchymal enhancement at greater risk for breast cancers with poor prognostic markers. Presented orally at the Society of Breast Imaging/American College of Radiology Breast Imaging Symposium April 2015, Orlando.
  • Mango V, Ha R, Friedlander LC, Hibshoosh H, Wynn RT. Male breast findings: the unusual suspects. Presented at the 100th Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 2014.
  • Friedlander LC, Lee CH, Comstock CE, Morris EA, Dershaw D. Frequency of unsuspected missed lesions and false-negative rate and MRI-guided core biopsy. Scientific poster presentation, 97th Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 2011.
  • Friedlander LC, Gavenonis S, Roth S. MRI screening for breast cancer in high-risk patients with lobular carcinoma in situ. Presented at the 96th Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 28, 2010.
  • Friedlander LC, Gavenonis S, Roth S. MRI screening for breast cancer in high-risk patients with lobular carcinoma in situ. Presented at Grand Rounds at the Hospital of the University of Pennsylvania, Philadelphia, PA. January 26, 2010.